Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis

Background. MS patients show a remarkable heterogeneity in their response to disease modifying treatments. Given the need for early treatment initiation and the diversity of available options, a predictive marker that indicates good or poor response to treatment is highly desirable. Objective. To fi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Dimisianos, Nikolaos, Rodi, Maria, Kalavrizioti, Dimitra, Georgiou, Vasileios, Papathanasopoulos, Panagiotis, Mouzaki, Athanasia
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2014
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4134814/
https://ncbi.nlm.nih.gov/pubmed/25152817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/436764
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi